Market closedNon-fractional
US Physical Therapy/USPH
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Ticker
USPH
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Houston, United States
Employees
5,310
Website
www.usph.com
USPH Metrics
BasicAdvanced
$1.4B
Market cap
76.36
P/E ratio
$1.20
EPS
1.39
Beta
$1.73
Dividend rate
1.89%
Dividend yield
Price and volume
Market cap
$1.4B
Beta
1.39
Dividend rate
$1.73
Financial strength
Current ratio
2.157
Quick ratio
2.042
Long term debt to equity
31.613
Total debt to equity
38.149
Dividend payout ratio (TTM)
83.56%
Interest coverage (TTM)
7.68%
Management effectiveness
Return on assets (TTM)
4.43%
Return on equity (TTM)
6.47%
Valuation
Price to earnings (TTM)
76.36
Price to revenue (TTM)
2.22
Price to book
2.89
Price to tangible book (TTM)
-8.09
Price to free cash flow (TTM)
20.39
Dividend yield (TTM)
1.89%
Growth
Revenue change (TTM)
7.35%
Earnings per share change (TTM)
-44.43%
3-year revenue growth
13.14%
3-year earnings per share growth
-21.56%
3-year dividend per share growth
70.34%
What the Analysts think about USPH
Analyst Ratings
Majority rating from 6 analysts.
USPH Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$156M
0.52%
Net income
$8M
1,233.33%
Profit margin
5.14%
1,252.63%
USPH Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.76
$0.62
$0.59
$0.51
-
Expected
$0.75
$0.62
$0.57
$0.56
$0.82
Surprise
1.60%
0.54%
4.12%
-8.66%
-
USPH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for US Physical Therapy stock?
US Physical Therapy (USPH) has a market cap of $1.4B as of July 05, 2024.
What is the P/E ratio for US Physical Therapy stock?
The price to earnings (P/E) ratio for US Physical Therapy (USPH) stock is 76.36 as of July 05, 2024.
Does US Physical Therapy stock pay dividends?
Yes, the US Physical Therapy (USPH) stock pays dividends to shareholders. As of July 05, 2024, the dividend rate is $1.73 and the yield is 1.89%. US Physical Therapy has a payout ratio of 83.56% on a trailing twelve-month basis.
When is the next US Physical Therapy dividend payment date?
The next US Physical Therapy (USPH) dividend payment date is unconfirmed.
What is the beta indicator for US Physical Therapy?
US Physical Therapy (USPH) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell US Physical Therapy stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell US Physical Therapy stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.